NCT00209950View on ClinicalTrials.gov

A Prospective Open-Label Extension Study of Gaboxadol in Primary Insomnia

PHASE3CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

July 31, 2004

Study Completion Date

September 30, 2005

Conditions
Primary Insomnia
Interventions
DRUG

Gaboxadol

Trial Locations (1)

Unknown

Non-US study, principal location:, Regensburg

All Listed Sponsors
lead

H. Lundbeck A/S

INDUSTRY

NCT00209950 - A Prospective Open-Label Extension Study of Gaboxadol in Primary Insomnia | Biotech Hunter | Biotech Hunter